Eric A. Toussirot
Department of Rheumatology
Jean Minjoz University Hospital
Bd Fleming
F-25030 Besançon Cedex
France
Name/email consistency: high
- The contribution of adipose tissue and adipokines to inflammation in joint diseases. Toussirot, E., Streit, G., Wendling, D. Curr. Med. Chem. (2007)
- Infectious complications with anti-TNFalpha therapy in rheumatic diseases: a review. Toussirot, E., Streit, G., Wendling, D. Recent. Pat. Inflamm. Allergy. Drug. Discov (2007)
- Bacterial extract (OM-89) specific and non specific immunomodulation in rheumatoid arthritis patients. Toussirot, E., Robinet, E., Saas, P., Chabod, J., Augé, B., Cozma, G., Tiberghien, P., Roudier, J., Wendling, D. Autoimmunity (2006)
- Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Toussirot, E., Nguyen, N.U., Dumoulin, G., Aubin, F., Cédoz, J.P., Wendling, D. Rheumatology. (Oxford) (2005)
- Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies. Toussirot, E., Wendling, D. Expert. Opin. Pharmacother (2005)
- Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment options. Toussirot, E., Wendling, D. Drugs. Aging (2005)
- The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview. Toussirot, E., Wendling, D. Expert. Opin. Pharmacother (2004)
- Recent progress in ankylosing spondylitis treatment. Toussirot, E., Wendling, D. Expert. Opin. Pharmacother (2003)
- Avascular necrosis of the hallucal sesamoids update with reference to two case-reports. Toussirot, E., Jeunet, L., Michel, F., Kantelip, B., Wendling, D. Joint. Bone. Spine (2003)
- Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren's syndrome and hepatitis C virus infection. Toussirot, E., Le Huédé, G., Mougin, C., Balblanc, J.C., Bettinger, D., Wendling, D. J. Rheumatol. (2002)
- Oral tolerance in the treatment of rheumatoid arthritis. Toussirot, E.A. Curr. Drug. Targets. Inflamm. Allergy (2002)
- Therapeutic advances in ankylosing spondylitis. Toussirot, E., Wendling, D. Expert. Opin. Investig. Drugs (2001)
- Fibromyalgia developed after administration of gonadotrophin-releasing hormone analogue. Toussirot, E., Wendling, D. Clin. Rheumatol. (2001)
- Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Toussirot, E., Wendling, D., Tiberghien, P., Luka, J., Roudier, J. Ann. Rheum. Dis. (2000)
- HLA DRB1* alleles in rheumatoid nodulosis: a comparative study with rheumatoid arthritis with and without nodules. Toussirot, E., Tiberghien, P., Balblanc, J.C., Kremer, P., Despaux, J., Dupond, J.L., Wendling, D. Rheumatol. Int. (1998)
- Current guidelines for the drug treatment of ankylosing spondylitis. Toussirot, E., Wendling, D. Drugs (1998)
